Company Overview
AngioDynamics is a medical technology company focused on restoring vascular blood flow, expanding cancer treatments, and improving patient quality of life.
Key Financial Figures
In the third quarter of fiscal 2026, total net sales were $78.4 million, reflecting an 8.9% year-over-year increase. The GAAP loss per share was $0.19, while the adjusted loss per share was $0.07.
Additional Financial Insights
The company reported an adjusted EBITDA of $1.8 million for the quarter. AngioDynamics ended the quarter with $37.8 million in cash and maintains a completely debt-free balance sheet.
